Deepak Ramdas Pednekar
About Deepak Ramdas Pednekar
Data last updated:
Deepak Ramdas Pednekar has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Haffkine Bio-Pharmaceutical Corporation Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Haffkine Bio-Pharmaceutical Corporation Limited at ₹176 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Haffkine Bio-Pharmaceutical Corporation Limited U24239MH1974SGC017341 | Director | 28 Jan 2021 | 1974 | ₹176 Cr (FY 2022) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Ramdas Pednekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Ramdas Pednekar
Deepak Ramdas Pednekar has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Haffkine Bio-Pharmaceutical Corporation Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Haffkine Bio-Pharmaceutical Corporation Limited at ₹176 Cr (FY 2022).
Deepak Ramdas Pednekar is associated with 1 company as Director, including Haffkine Bio-Pharmaceutical Corporation Limited (₹176 Cr).
Deepak Ramdas Pednekar has expertise in General Business.
Deepak Ramdas Pednekar has 5 years in corporate governance.
By reported revenue, the largest current company of Deepak Ramdas Pednekar is Haffkine Bio-Pharmaceutical Corporation Limited, with revenue of ₹176 Cr (FY 2022).
Deepak Ramdas Pednekar currently holds positions at 1 company: Haffkine Bio-Pharmaceutical Corporation Limited (₹176 Cr).